Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly kinase inhibitors and antiviral agents. Its structure supports the development of targeted therapies in oncology, including treatments for leukemia and other cancers. Commonly employed in medicinal chemistry for scaffold modification to enhance drug potency and selectivity. Also utilized in research settings for the design of novel bioactive molecules due to its resemblance to purine bases, enabling interactions with enzymes and receptors involved in cellular signaling pathways.